Follow
chiara laezza
chiara laezza
IEOS CNR
No verified email
Title
Cited by
Cited by
Year
Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma
A Ligresti, AS Moriello, K Starowicz, I Matias, S Pisanti, L De Petrocellis, ...
Journal of Pharmacology and Experimental Therapeutics 318 (3), 1375-1387, 2006
7022006
Cannabidiol: State of the art and new challenges for therapeutic applications
S Pisanti, AM Malfitano, E Ciaglia, A Lamberti, R Ranieri, G Cuomo, ...
Pharmacology & therapeutics 175, 133-150, 2017
6152017
Pharmacological actions of statins: a critical appraisal in the management of cancer
P Gazzerro, MC Proto, G Gangemi, AM Malfitano, E Ciaglia, S Pisanti, ...
Pharmacological reviews 64 (1), 102-146, 2012
5482012
The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation
L De Petrocellis, D Melck, A Palmisano, T Bisogno, C Laezza, M Bifulco, ...
Proceedings of the National Academy of Sciences 95 (14), 8375-8380, 1998
5451998
Suppression of nerve growth factor Trk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferation
D Melck, L De Petrocellis, P Orlando, T Bisogno, C Laezza, M Bifulco, ...
Endocrinology 141 (1), 118-126, 2000
3122000
Inhibitory effects of cannabinoid CB1 receptor stimulation on tumor growth and metastatic spreading: actions on signals involved in angiogenesis and metastasis
G Portella, C Laezza, P Laccetti, L De Petrocellis, V Di Marzo, M Bifulco
The FASEB Journal 17 (12), 1771-1773, 2003
2462003
The endocannabinoid signaling system in cancer
S Pisanti, P Picardi, A D’Alessandro, C Laezza, M Bifulco
Trends in pharmacological sciences 34 (5), 273-282, 2013
2332013
Cannabinoids and cancer: pros and cons of an antitumour strategy
M Bifulco, C Laezza, S Pisanti, P Gazzerro
British journal of pharmacology 148 (2), 123-135, 2006
2122006
Anandamide inhibits adhesion and migration of breast cancer cells
C Grimaldi, S Pisanti, C Laezza, AM Malfitano, A Santoro, M Vitale, ...
Experimental cell research 312 (4), 363-373, 2006
2032006
2′, 3′-Cyclic nucleotide 3′-phosphodiesterase: a membrane-bound, microtubule-associated protein and membrane anchor for tubulin
M Bifulco, C Laezza, S Stingo, J Wolff
Proceedings of the National Academy of Sciences 99 (4), 1807-1812, 2002
1782002
Control by the endogenous cannabinoid system of ras oncogene‐dependent tumor growth
M Bifulco, C Laezza, G Portella, M Vitale, P Orlando, L De Petrocellis, ...
The FASEB Journal 15 (14), 1-17, 2001
1752001
A new strategy to block tumor growth by inhibiting endocannabinoid inactivation
M Bifulco, C Laezza, M Valenti, A Ligresti, G Portella, V Di Marzo
The FASEB journal 18 (13), 1606-1608, 2004
1622004
The cannabinoid CB1 receptor antagonist rimonabant (SR141716) inhibits human breast cancer cell proliferation through a lipid raft-mediated mechanism
D Sarnataro, S Pisanti, A Santoro, P Gazzerro, AM Malfitano, C Laezza, ...
Molecular pharmacology 70 (4), 1298-1306, 2006
1402006
Antiangiogenic activity of the endocannabinoid anandamide: correlation to its tumor‐suppressor efficacy
S Pisanti, C Borselli, O Oliviero, C Laezza, P Gazzerro, M Bifulco
Journal of cellular physiology 211 (2), 495-503, 2007
1292007
The endocannabinoid system: A target for cancer treatment
C Laezza, C Pagano, G Navarra, O Pastorino, MC Proto, D Fiore, ...
International journal of molecular sciences 21 (3), 747, 2020
1242020
The cannabinoid CB1 receptor antagonist rimonabant stimulates 2-deoxyglucose uptake in skeletal muscle cells by regulating the expression of phosphatidylinositol-3-kinase
I Esposito, MC Proto, P Gazzerro, C Laezza, C Miele, AT Alberobello, ...
Molecular pharmacology 74 (6), 1678-1686, 2008
1142008
Use of cannabinoid receptor agonists in cancer therapy as palliative and curative agents
S Pisanti, AM Malfitano, C Grimaldi, A Santoro, P Gazzerro, C Laezza, ...
Best Practice & Research Clinical Endocrinology & Metabolism 23 (1), 117-131, 2009
1112009
Anandamide inhibits Cdk2 and activates Chk1 leading to cell cycle arrest in human breast cancer cells
C Laezza, S Pisanti, E Crescenzi, M Bifulco
FEBS letters 580 (26), 6076-6082, 2006
1072006
Cannabinoids: therapeutic use in clinical practice
C Pagano, G Navarra, L Coppola, G Avilia, M Bifulco, C Laezza
International journal of molecular sciences 23 (6), 3344, 2022
1062022
Update on the endocannabinoid system as an anticancer target
AM Malfitano, E Ciaglia, G Gangemi, P Gazzerro, C Laezza, M Bifulco
Expert opinion on therapeutic targets 15 (3), 297-308, 2011
1052011
The system can't perform the operation now. Try again later.
Articles 1–20